BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 15471549)

  • 21. A pilot control trial of schistosomiasis in central Liberia by mass chemotherapy of target populations, combined with focal application of molluscicide.
    Saladin B; Saladin K; Holzer B; Dennis E; Hanson A; Degrémont A
    Acta Trop; 1983 Sep; 40(3):271-95. PubMed ID: 6138977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections.
    N'Goran EK; Utzinger J; Gnaka HN; Yapi A; N'Guessan NA; Kigbafori SD; Lengeler C; Chollet J; Shuhua X; Tanner M
    Am J Trop Med Hyg; 2003 Jan; 68(1):24-32. PubMed ID: 12556143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Some factors affecting prevalence of and immune responses to Schistosoma mansoni in schoolchildren in Gorgora, northwest Ethiopia.
    Degu G; Mengistu G; Jones J
    Ethiop Med J; 2002 Oct; 40(4):345-52. PubMed ID: 12596654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial.
    Keiser J; N'Guessan NA; Adoubryn KD; Silué KD; Vounatsou P; Hatz C; Utzinger J; N'Goran EK
    Clin Infect Dis; 2010 May; 50(9):1205-13. PubMed ID: 20350194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Heterogeneity of Schistosoma haematobium transmission in irrigated fields].
    Ernould JC; Garba A; Labbo R; Kaman AK; Sidiki A; Djibrilla A; Chippaux JP
    Bull Soc Pathol Exot; 2004 Feb; 97(1):19-23. PubMed ID: 15104152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire.
    N'Goran EK; Gnaka HN; Tanner M; Utzinger J
    Ann Trop Med Parasitol; 2003 Jan; 97(1):37-51. PubMed ID: 12662421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection status and risk factors associated with urinary schistosomiasis among school-going children in the Ndumo area of uMkhanyakude District in KwaZulu-Natal, South Africa two years post-treatment.
    Kabuyaya M; Chimbari MJ; Mukaratirwa S
    Int J Infect Dis; 2018 Jun; 71():100-106. PubMed ID: 29679769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Praziquantel efficacy and long-term appraisal of schistosomiasis control in Pemba Island.
    Guidi A; Andolina C; Makame Ame S; Albonico M; Cioli D; Juma Haji H
    Trop Med Int Health; 2010 May; 15(5):614-8. PubMed ID: 20214757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some aspects in the control of schistosomosis and soil-transmitted helminthosis in Yemeni children.
    Raja'a YA; Sulaiman SM; Mubarak JS; El-Bakri MM; Al-Adimi WH; El-Nabihi MT; El-Dhobri MA; Raja'a JA
    Saudi Med J; 2001 May; 22(5):428-32. PubMed ID: 11376386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
    Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.
    Phillips AE; Gazzinelli-Guimaraes PH; Aurelio HO; Ferro J; Nala R; Clements M; King CH; Fenwick A; Fleming FM; Dhanani N
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006061. PubMed ID: 29220347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of the community-directed treatment approach versus the school-based treatment approach on the prevalence and intensity of schistosomiasis and soil-transmitted helminthiasis among schoolchildren in Tanzania.
    Massa K; Magnussen P; Sheshe A; Ntakamulenga R; Ndawi B; Olsen A
    Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):31-7. PubMed ID: 18771789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of praziquantel efficacy at 40 mg/kg and 60 mg/kg in treating Schistosoma haematobium infection among schoolchildren in the Ingwavuma area, KwaZulu-Natal, South Africa.
    Kabuyaya M; Chimbari MJ; Mukaratirwa S
    S Afr Med J; 2020 Jul; 110(7):657-660. PubMed ID: 32880343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso.
    Touré S; Zhang Y; Bosqué-Oliva E; Ky C; Ouedraogo A; Koukounari A; Gabrielli AF; Bertrand S; Webster JP; Fenwick A
    Bull World Health Organ; 2008 Oct; 86(10):780-7, A. PubMed ID: 18949215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of single dose versus two doses of praziquantel on Schistosoma haematobium infection and pathology among school-aged children in Mali.
    Sacko M; Magnussen P; Traoré M; Landouré A; Doucouré A; Reimert CM; Vennervald BJ
    Parasitology; 2009 Nov; 136(13):1851-7. PubMed ID: 19281636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia.
    Mwanakasale V; Vounatsou P; Sukwa TY; Ziba M; Ernest A; Tanner M
    Am J Trop Med Hyg; 2003 Oct; 69(4):420-8. PubMed ID: 14640503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study.
    Borrmann S; Szlezák N; Faucher JF; Matsiegui PB; Neubauer R; Binder RK; Lell B; Kremsner PG
    J Infect Dis; 2001 Nov; 184(10):1363-6. PubMed ID: 11679932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of different approaches to mass delivery of praziquantel among school-aged children in rural communities in Nigeria.
    Mafe MA; Appelt B; Adewale B; Idowu ET; Akinwale OP; Adeneye AK; Manafa OU; Sulyman MA; Akande OD; Omotola BD
    Acta Trop; 2005 Feb; 93(2):181-90. PubMed ID: 15652332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity.
    Chisango TJ; Ndlovu B; Vengesai A; Nhidza AF; Sibanda EP; Zhou D; Mutapi F; Mduluza T
    BMC Infect Dis; 2019 Mar; 19(1):219. PubMed ID: 30832614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of praziquantel drug against Schistosoma haematobium and performance of urine reagent strips among pre-and-school aged children during the high transmission season in North-Western Tanzania.
    Mazigo HD; Kayange N; Ambrose EE; Zinga MM; Mugassa S; Ruganuza D; Mwingira UJ; Uisso C; Mutapi F
    Acta Trop; 2024 Aug; 256():107232. PubMed ID: 38729329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.